| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 63 | 2025 | 236 | 15.700 |
Why?
|
| Endovascular Procedures | 56 | 2025 | 333 | 15.020 |
Why?
|
| Aortic Aneurysm, Abdominal | 41 | 2025 | 120 | 11.930 |
Why?
|
| Blood Vessel Prosthesis | 47 | 2025 | 242 | 8.780 |
Why?
|
| Stents | 43 | 2025 | 409 | 6.610 |
Why?
|
| Aortic Aneurysm, Thoracic | 23 | 2025 | 97 | 5.670 |
Why?
|
| Aortic Rupture | 14 | 2024 | 52 | 4.130 |
Why?
|
| Endoleak | 21 | 2024 | 42 | 3.900 |
Why?
|
| Prosthesis Design | 31 | 2025 | 297 | 3.790 |
Why?
|
| Iliac Aneurysm | 6 | 2024 | 8 | 2.610 |
Why?
|
| Aortic Aneurysm | 7 | 2025 | 71 | 2.550 |
Why?
|
| Vascular Surgical Procedures | 8 | 2025 | 150 | 2.300 |
Why?
|
| Treatment Outcome | 59 | 2025 | 9104 | 2.130 |
Why?
|
| Venous Thrombosis | 6 | 2021 | 257 | 1.950 |
Why?
|
| Arteriovenous Shunt, Surgical | 3 | 2023 | 72 | 1.900 |
Why?
|
| Aortic Diseases | 8 | 2024 | 87 | 1.790 |
Why?
|
| Registries | 20 | 2025 | 993 | 1.760 |
Why?
|
| Aorta, Thoracic | 15 | 2025 | 149 | 1.690 |
Why?
|
| Risk Factors | 38 | 2025 | 5903 | 1.650 |
Why?
|
| Aorta | 8 | 2024 | 273 | 1.520 |
Why?
|
| Arterial Occlusive Diseases | 4 | 2024 | 106 | 1.520 |
Why?
|
| Iliac Artery | 5 | 2024 | 41 | 1.340 |
Why?
|
| Humans | 116 | 2025 | 93541 | 1.280 |
Why?
|
| Models, Cardiovascular | 5 | 2025 | 92 | 1.260 |
Why?
|
| Retrospective Studies | 39 | 2025 | 10168 | 1.260 |
Why?
|
| Femoral Artery | 3 | 2025 | 90 | 1.250 |
Why?
|
| Postoperative Complications | 23 | 2025 | 2563 | 1.240 |
Why?
|
| Time Factors | 30 | 2025 | 5412 | 1.170 |
Why?
|
| Aged | 52 | 2025 | 20439 | 1.090 |
Why?
|
| Prosthesis Failure | 9 | 2024 | 123 | 1.080 |
Why?
|
| Vena Cava, Inferior | 3 | 2022 | 139 | 1.060 |
Why?
|
| Aged, 80 and over | 31 | 2025 | 7063 | 1.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 4 | 2020 | 42 | 0.960 |
Why?
|
| Vascular Diseases | 2 | 2020 | 118 | 0.930 |
Why?
|
| Dissection | 1 | 2025 | 45 | 0.900 |
Why?
|
| Catheterization, Peripheral | 4 | 2020 | 60 | 0.890 |
Why?
|
| Patient-Specific Modeling | 3 | 2025 | 24 | 0.880 |
Why?
|
| Male | 63 | 2025 | 44570 | 0.880 |
Why?
|
| Anastomosis, Surgical | 2 | 2025 | 280 | 0.880 |
Why?
|
| Lost to Follow-Up | 1 | 2024 | 15 | 0.840 |
Why?
|
| Risk Assessment | 21 | 2024 | 2441 | 0.830 |
Why?
|
| Aorta, Abdominal | 5 | 2021 | 58 | 0.820 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2023 | 180 | 0.790 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 338 | 0.780 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 333 | 0.770 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 108 | 0.750 |
Why?
|
| Female | 55 | 2025 | 48719 | 0.740 |
Why?
|
| Endarterectomy, Carotid | 3 | 2020 | 75 | 0.720 |
Why?
|
| Vascular Patency | 6 | 2024 | 118 | 0.720 |
Why?
|
| Lower Extremity | 2 | 2012 | 99 | 0.700 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2020 | 7 | 0.670 |
Why?
|
| Kidney Pelvis | 1 | 2021 | 50 | 0.660 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2012 | 56 | 0.650 |
Why?
|
| Carotid Stenosis | 2 | 2020 | 114 | 0.650 |
Why?
|
| Coronary Stenosis | 1 | 2020 | 31 | 0.650 |
Why?
|
| Angioplasty | 4 | 2006 | 68 | 0.650 |
Why?
|
| Carotid Artery, Internal | 1 | 2020 | 69 | 0.640 |
Why?
|
| Situs Inversus | 1 | 2020 | 16 | 0.640 |
Why?
|
| Education, Medical | 1 | 2023 | 228 | 0.640 |
Why?
|
| Jehovah's Witnesses | 1 | 2020 | 21 | 0.630 |
Why?
|
| Collateral Circulation | 1 | 2020 | 37 | 0.630 |
Why?
|
| Prosthesis-Related Infections | 3 | 2021 | 61 | 0.630 |
Why?
|
| Upper Extremity | 1 | 2020 | 64 | 0.620 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2020 | 92 | 0.620 |
Why?
|
| Aortography | 10 | 2025 | 57 | 0.620 |
Why?
|
| Betacoronavirus | 4 | 2020 | 283 | 0.600 |
Why?
|
| Robotic Surgical Procedures | 1 | 2025 | 368 | 0.590 |
Why?
|
| Middle Aged | 36 | 2025 | 27583 | 0.590 |
Why?
|
| Terminology as Topic | 2 | 2023 | 218 | 0.580 |
Why?
|
| Renal Dialysis | 3 | 2023 | 350 | 0.570 |
Why?
|
| Leg | 2 | 2013 | 140 | 0.560 |
Why?
|
| Kidney Diseases | 1 | 2021 | 315 | 0.560 |
Why?
|
| Iliac Vein | 2 | 2010 | 32 | 0.550 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 1103 | 0.530 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 272 | 0.530 |
Why?
|
| Physicians | 2 | 2021 | 682 | 0.520 |
Why?
|
| Finite Element Analysis | 5 | 2025 | 75 | 0.510 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2013 | 624 | 0.490 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 375 | 0.470 |
Why?
|
| Device Removal | 2 | 2021 | 168 | 0.470 |
Why?
|
| Computed Tomography Angiography | 6 | 2025 | 164 | 0.460 |
Why?
|
| Aneurysm, Infected | 3 | 2010 | 14 | 0.460 |
Why?
|
| Patient Transfer | 1 | 2016 | 108 | 0.450 |
Why?
|
| Aneurysm | 2 | 2015 | 57 | 0.440 |
Why?
|
| Aneurysm, Ruptured | 3 | 2020 | 61 | 0.430 |
Why?
|
| Surgery Department, Hospital | 3 | 2020 | 43 | 0.410 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2020 | 89 | 0.410 |
Why?
|
| Healthcare Disparities | 3 | 2024 | 486 | 0.380 |
Why?
|
| Leg Ulcer | 1 | 2012 | 7 | 0.380 |
Why?
|
| Anticoagulants | 2 | 2013 | 457 | 0.370 |
Why?
|
| Diabetic Angiopathies | 1 | 2012 | 37 | 0.370 |
Why?
|
| Embolic Protection Devices | 1 | 2012 | 9 | 0.370 |
Why?
|
| Heparin | 1 | 2013 | 181 | 0.370 |
Why?
|
| Embolism | 1 | 2012 | 32 | 0.360 |
Why?
|
| Pandemics | 5 | 2020 | 873 | 0.360 |
Why?
|
| Transducers, Pressure | 3 | 2011 | 6 | 0.360 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 89 | 0.360 |
Why?
|
| United States | 12 | 2023 | 7624 | 0.350 |
Why?
|
| Limb Salvage | 1 | 2012 | 38 | 0.350 |
Why?
|
| Reoperation | 7 | 2021 | 703 | 0.350 |
Why?
|
| Catheters, Indwelling | 1 | 2012 | 101 | 0.350 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 452 | 0.350 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2020 | 2585 | 0.350 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2011 | 10 | 0.340 |
Why?
|
| Monitoring, Ambulatory | 1 | 2011 | 32 | 0.330 |
Why?
|
| Septal Occluder Device | 1 | 2011 | 49 | 0.320 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 59 | 0.320 |
Why?
|
| Bicycling | 1 | 2010 | 16 | 0.310 |
Why?
|
| Carotid Artery Diseases | 1 | 2011 | 100 | 0.310 |
Why?
|
| Cerebrovascular Disorders | 1 | 2011 | 140 | 0.310 |
Why?
|
| Predictive Value of Tests | 4 | 2023 | 1713 | 0.300 |
Why?
|
| Stroke | 5 | 2023 | 1079 | 0.300 |
Why?
|
| Health Status Disparities | 2 | 2023 | 219 | 0.290 |
Why?
|
| Sex Factors | 5 | 2020 | 1105 | 0.290 |
Why?
|
| Foreign-Body Migration | 2 | 2024 | 32 | 0.290 |
Why?
|
| Balloon Occlusion | 2 | 2005 | 28 | 0.280 |
Why?
|
| Subclavian Artery | 4 | 2021 | 40 | 0.280 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 429 | 0.270 |
Why?
|
| Fibrinolytic Agents | 4 | 2011 | 239 | 0.260 |
Why?
|
| Diverticulum | 2 | 2020 | 44 | 0.260 |
Why?
|
| Multiple Trauma | 2 | 2006 | 37 | 0.260 |
Why?
|
| Groin | 2 | 2025 | 11 | 0.250 |
Why?
|
| Nephrectomy | 1 | 2009 | 293 | 0.250 |
Why?
|
| Thyroid Neoplasms | 1 | 2011 | 442 | 0.250 |
Why?
|
| Vascular Fistula | 2 | 2020 | 12 | 0.250 |
Why?
|
| Telemetry | 1 | 2006 | 30 | 0.240 |
Why?
|
| Deglutition Disorders | 2 | 2020 | 126 | 0.240 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2006 | 114 | 0.230 |
Why?
|
| Incidence | 3 | 2020 | 1702 | 0.230 |
Why?
|
| Aneurysm, False | 2 | 2010 | 52 | 0.230 |
Why?
|
| Cadaver | 1 | 2025 | 199 | 0.220 |
Why?
|
| Bloodless Medical and Surgical Procedures | 1 | 2025 | 6 | 0.220 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 361 | 0.220 |
Why?
|
| Postoperative Care | 1 | 2006 | 235 | 0.220 |
Why?
|
| Angioplasty, Balloon | 3 | 2012 | 90 | 0.220 |
Why?
|
| Metals | 1 | 2025 | 102 | 0.220 |
Why?
|
| Treatment Refusal | 1 | 2025 | 68 | 0.210 |
Why?
|
| Lithotripsy | 1 | 2024 | 43 | 0.210 |
Why?
|
| Consensus | 2 | 2019 | 368 | 0.210 |
Why?
|
| Intraoperative Complications | 3 | 2010 | 195 | 0.210 |
Why?
|
| Blood Pressure Monitors | 1 | 2004 | 9 | 0.210 |
Why?
|
| Blood Loss, Surgical | 1 | 2025 | 131 | 0.210 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2004 | 18 | 0.210 |
Why?
|
| Blood Pressure Determination | 1 | 2004 | 69 | 0.210 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2004 | 20 | 0.200 |
Why?
|
| Comorbidity | 5 | 2020 | 1007 | 0.200 |
Why?
|
| Quality of Life | 1 | 2012 | 1782 | 0.200 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 546 | 0.200 |
Why?
|
| Thrombosis | 2 | 2018 | 309 | 0.200 |
Why?
|
| Blood Transfusion | 1 | 2025 | 175 | 0.200 |
Why?
|
| Thrombolytic Therapy | 2 | 2020 | 254 | 0.200 |
Why?
|
| Europe | 3 | 2020 | 337 | 0.200 |
Why?
|
| Hemostasis, Surgical | 1 | 2003 | 23 | 0.200 |
Why?
|
| Stress, Mechanical | 2 | 2025 | 248 | 0.200 |
Why?
|
| Feasibility Studies | 1 | 2025 | 756 | 0.190 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 263 | 0.190 |
Why?
|
| Surgical Wound Infection | 1 | 2025 | 237 | 0.190 |
Why?
|
| Patient Selection | 2 | 2020 | 690 | 0.190 |
Why?
|
| Arteries | 2 | 2022 | 171 | 0.190 |
Why?
|
| Hospital Costs | 1 | 2023 | 116 | 0.190 |
Why?
|
| Ulcer | 2 | 2020 | 38 | 0.190 |
Why?
|
| Radiography | 4 | 2012 | 790 | 0.180 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 284 | 0.180 |
Why?
|
| Schools, Medical | 1 | 2023 | 132 | 0.180 |
Why?
|
| Mentors | 1 | 2023 | 98 | 0.180 |
Why?
|
| Retreatment | 2 | 2021 | 104 | 0.180 |
Why?
|
| Infection Control | 2 | 2020 | 131 | 0.180 |
Why?
|
| Ischemia | 1 | 2004 | 253 | 0.180 |
Why?
|
| Saphenous Vein | 1 | 2021 | 59 | 0.180 |
Why?
|
| Hematoma | 2 | 2020 | 106 | 0.180 |
Why?
|
| Spinal Cord Ischemia | 1 | 2021 | 8 | 0.170 |
Why?
|
| Sex Distribution | 2 | 2020 | 174 | 0.170 |
Why?
|
| Students | 1 | 2023 | 179 | 0.170 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 286 | 0.170 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 624 | 0.170 |
Why?
|
| Dilatation | 1 | 2021 | 47 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 876 | 0.170 |
Why?
|
| Treatment Failure | 2 | 2012 | 293 | 0.170 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2015 | 7 | 0.170 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 75 | 0.170 |
Why?
|
| Phlebography | 2 | 2011 | 68 | 0.160 |
Why?
|
| Intestines | 1 | 2004 | 432 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2023 | 291 | 0.160 |
Why?
|
| Intestinal Fistula | 1 | 2020 | 30 | 0.160 |
Why?
|
| Needs Assessment | 1 | 2021 | 169 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2013 | 236 | 0.160 |
Why?
|
| Clinical Competence | 1 | 2006 | 822 | 0.160 |
Why?
|
| Clinical Clerkship | 1 | 2021 | 120 | 0.160 |
Why?
|
| Medicare | 1 | 2023 | 455 | 0.160 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 186 | 0.160 |
Why?
|
| Catheters | 1 | 2020 | 96 | 0.150 |
Why?
|
| Cysts | 2 | 2015 | 99 | 0.150 |
Why?
|
| Body Mass Index | 1 | 2023 | 811 | 0.150 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2023 | 269 | 0.150 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 57 | 0.150 |
Why?
|
| Health Resources | 1 | 2020 | 80 | 0.150 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 179 | 0.150 |
Why?
|
| Cause of Death | 2 | 2018 | 273 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2011 | 179 | 0.140 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 225 | 0.140 |
Why?
|
| Death Certificates | 1 | 2018 | 11 | 0.140 |
Why?
|
| New Zealand | 1 | 2018 | 23 | 0.140 |
Why?
|
| Thrombectomy | 1 | 2020 | 220 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2023 | 576 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2023 | 1918 | 0.140 |
Why?
|
| Device Approval | 1 | 2018 | 14 | 0.140 |
Why?
|
| Brazil | 1 | 2018 | 81 | 0.140 |
Why?
|
| Australia | 1 | 2018 | 123 | 0.140 |
Why?
|
| Age Distribution | 1 | 2018 | 206 | 0.130 |
Why?
|
| Biomechanical Phenomena | 1 | 2019 | 489 | 0.130 |
Why?
|
| Surgical Procedures, Operative | 1 | 2020 | 217 | 0.130 |
Why?
|
| Diabetic Foot | 1 | 2017 | 16 | 0.130 |
Why?
|
| Informed Consent | 1 | 2020 | 277 | 0.130 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 77 | 0.130 |
Why?
|
| Databases, Factual | 2 | 2020 | 1006 | 0.130 |
Why?
|
| General Surgery | 1 | 2020 | 248 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 356 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 461 | 0.130 |
Why?
|
| Constriction, Pathologic | 2 | 2010 | 207 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 142 | 0.130 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 163 | 0.120 |
Why?
|
| Adult | 10 | 2024 | 27930 | 0.120 |
Why?
|
| Obesity | 1 | 2023 | 1018 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 425 | 0.120 |
Why?
|
| Students, Medical | 1 | 2021 | 437 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 609 | 0.120 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 43 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2019 | 961 | 0.120 |
Why?
|
| Acute Disease | 3 | 2025 | 841 | 0.110 |
Why?
|
| Goals | 1 | 2015 | 67 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 1054 | 0.110 |
Why?
|
| Vascular Malformations | 1 | 2015 | 19 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 140 | 0.110 |
Why?
|
| Decision Making | 1 | 2020 | 674 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 3832 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 882 | 0.100 |
Why?
|
| Prospective Studies | 5 | 2024 | 4563 | 0.100 |
Why?
|
| Swine | 2 | 2004 | 588 | 0.090 |
Why?
|
| Suture Techniques | 2 | 2024 | 142 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2013 | 285 | 0.090 |
Why?
|
| Vena Cava Filters | 1 | 2013 | 89 | 0.090 |
Why?
|
| Algorithms | 1 | 2020 | 1954 | 0.090 |
Why?
|
| Equipment Design | 2 | 2011 | 416 | 0.090 |
Why?
|
| Ankle Brachial Index | 1 | 2012 | 27 | 0.090 |
Why?
|
| Research Design | 1 | 2015 | 618 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 829 | 0.090 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2011 | 20 | 0.090 |
Why?
|
| Illinois | 1 | 2013 | 520 | 0.090 |
Why?
|
| Carotid Artery, Common | 1 | 2011 | 27 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 269 | 0.080 |
Why?
|
| Bronchial Fistula | 1 | 2011 | 10 | 0.080 |
Why?
|
| Neck Dissection | 1 | 2011 | 67 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2020 | 1091 | 0.080 |
Why?
|
| National Health Programs | 1 | 2011 | 18 | 0.080 |
Why?
|
| Germany | 1 | 2011 | 81 | 0.080 |
Why?
|
| Asymptomatic Diseases | 1 | 2011 | 43 | 0.080 |
Why?
|
| Computer Simulation | 2 | 2025 | 1118 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 2802 | 0.080 |
Why?
|
| Pressure | 1 | 2011 | 166 | 0.080 |
Why?
|
| Thyroidectomy | 1 | 2011 | 173 | 0.080 |
Why?
|
| Hypolipidemic Agents | 1 | 2011 | 96 | 0.080 |
Why?
|
| Length of Stay | 2 | 2014 | 828 | 0.080 |
Why?
|
| Triage | 2 | 2020 | 131 | 0.070 |
Why?
|
| Hospital Mortality | 3 | 2020 | 482 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 262 | 0.070 |
Why?
|
| Angiography | 2 | 2006 | 192 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2009 | 97 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 450 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 379 | 0.070 |
Why?
|
| Adolescent | 4 | 2021 | 9608 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2004 | 2495 | 0.060 |
Why?
|
| Survival Rate | 3 | 2020 | 1948 | 0.060 |
Why?
|
| Accidental Falls | 1 | 2006 | 48 | 0.060 |
Why?
|
| Chicago | 2 | 2020 | 1464 | 0.060 |
Why?
|
| Forecasting | 1 | 2006 | 293 | 0.060 |
Why?
|
| Catheterization | 1 | 2006 | 218 | 0.060 |
Why?
|
| Syndrome | 1 | 2006 | 437 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 1448 | 0.050 |
Why?
|
| Hepatic Veins | 1 | 2004 | 25 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2006 | 310 | 0.050 |
Why?
|
| Calibration | 1 | 2004 | 106 | 0.050 |
Why?
|
| Miniaturization | 1 | 2004 | 12 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2004 | 129 | 0.050 |
Why?
|
| Constriction | 1 | 2003 | 27 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2006 | 896 | 0.050 |
Why?
|
| Critical Illness | 1 | 2005 | 343 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 106 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2025 | 713 | 0.040 |
Why?
|
| Propensity Score | 1 | 2022 | 178 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2003 | 99 | 0.040 |
Why?
|
| Critical Care | 1 | 2005 | 444 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2023 | 185 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 28 | 0.040 |
Why?
|
| Cognition | 1 | 2006 | 627 | 0.040 |
Why?
|
| Educational Status | 1 | 2021 | 197 | 0.040 |
Why?
|
| Georgia | 2 | 2011 | 37 | 0.040 |
Why?
|
| Calcinosis | 1 | 2002 | 222 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 40 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2002 | 274 | 0.040 |
Why?
|
| Education, Distance | 1 | 2020 | 25 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 2020 | 46 | 0.040 |
Why?
|
| Uncertainty | 1 | 2020 | 78 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 53 | 0.040 |
Why?
|
| Age Factors | 2 | 2020 | 1906 | 0.040 |
Why?
|
| Workload | 1 | 2020 | 126 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2020 | 98 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 657 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2715 | 0.030 |
Why?
|
| Internet | 1 | 2020 | 337 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 594 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1321 | 0.030 |
Why?
|
| Animals | 2 | 2004 | 28156 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3912 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 6933 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2014 | 356 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2010 | 15 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2011 | 188 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 210 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2011 | 175 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2010 | 163 | 0.020 |
Why?
|
| Creatinine | 1 | 2009 | 293 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 889 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 3057 | 0.020 |
Why?
|
| Graft Survival | 1 | 2010 | 937 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 181 | 0.010 |
Why?
|
| Sutures | 1 | 2006 | 58 | 0.010 |
Why?
|
| Equipment Failure | 1 | 2006 | 118 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2005 | 161 | 0.010 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2005 | 148 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2004 | 102 | 0.010 |
Why?
|
| Polyesters | 1 | 2003 | 44 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 226 | 0.010 |
Why?
|
| Child | 1 | 2015 | 7357 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2004 | 177 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 1723 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 1524 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 189 | 0.010 |
Why?
|
| Ischemic Attack, Transient | 1 | 2002 | 184 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1799 | 0.010 |
Why?
|